Neogenomics (NEO) PT Raised to $24 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $16.35 +2.06%
Rating Summary:
15 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
15 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Needham & Company analyst Mike Matson raised the price target on Neogenomics (NASDAQ: NEO) to $24.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Piper Sandler: 'Neogenomics (NEO) Is Winning the Community'
- Enovix Corporation (ENVX) PT Lowered to $10 at StoneX
- Zeta Global Holdings Corp (ZETA) PT Raised to $38 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
